Yale ChIP Sites Track Settings
 
Yale ChIP-chip Sites   (Yale ChIP)

This track is part of a parent called 'Yale ChIP'. To show other tracks of this parent, go to the Yale ChIP configuration page.

Display mode:       Reset to defaults

Show only items with score at or above:   (range: 0 to 1000)

  Show only items in top-scoring   (range: 1 to 100,000)

Select subtracks:
    All                    
    Cell_Type
            HeLaS3
            GM06990
            K562
    Factor
            BAF155
            BAF170
            c-Fos
            c-Jun
            TAF1
            Pol2
            Pol2-N
            H4Kac4
            H3K27me3
            BAF47
            STAT1
            P65-C
            P65-N
            SMARCA4
            SMARCA6
            NRSF
List subtracks: only selected/visible    all    ()  
dense
 YU BAF155 HeLa  Yale ChIP-chip (BAF155 ab, HeLa S3 cells) Sites   schema 
dense
 YU BAF170 HeLa  Yale ChIP-chip (BAF170 ab, HeLa S3 cells) Sites   schema 
dense
 YU c-Fos HeLa  Yale ChIP-chip (c-Fos ab, HeLa S3 cells) Sites   schema 
dense
 YU c-Jun HeLa  Yale ChIP-chip (c-Jun ab, HeLa S3 cells) Sites   schema 
dense
 YU TAF1 HeLa  Yale ChIP-chip (TAF1 ab, HeLa S3 cells) Sites   schema 
dense
 YU Pol2 HeLa  Yale ChIP-chip (Pol2 ab, HeLa S3 cells) Sites   schema 
dense
 YU Pol2N HeLa  Yale ChIP-chip (Pol2 N-terminus ab, HeLa S3 cells) Sites   schema 
dense
 YU H4Kac4 HeLa  Yale ChIP-chip (H4Kac4 ab, HeLa S3 cells) Sites   schema 
dense
 YU H3K27me3 HeLa  Yale ChIP-chip (H3K27me3 ab, HeLa S3 cells) Sites   schema 
dense
 YU STAT1 HeLa IF  Yale ChIP-chip (STAT1 ab, HeLa S3 cells, Interferon-alpha treated) Sites   schema 
dense
 YU P65-N HeLa TNF  Yale ChIP-chip (NFKB p65 N-terminus ab, HeLa S3 cells, TNF-alpha treated) Sites   schema 
dense
 YU P65-C HeLa TNF  Yale ChIP-chip (NFKB p65 C-terminus ab, HeLa S3 cells, TNF-alpha treated) Sites   schema 
dense
 YU SMARCA4 HeLa  Yale ChIP-chip (SMARCA4, HeLa S3 cells) Sites   schema 
dense
 YU SMARCA6 HeLa  Yale ChIP-chip (SMARCA6, HeLa S3 cells) Sites   schema 
dense
 YU NRSF HeLa  Yale ChIP-chip (NRSF, HeLa S3 cells) Sites   schema 
dense
 YU Pol2 GM  Yale ChIP-chip (Pol2 ab, GM06990 cells) Sites   schema 
dense
 YU Pol2N GM  Yale ChIP-chip (Pol2 N-terminus ab, GM06990 cells) Sites   schema 
dense
 YU H4Kac4 GM  Yale ChIP-chip (H4Kac4 ab, GM06990 cells) Sites   schema 
dense
 YU BAF155 K562  Yale ChIP-chip (BAF155 ab, K562 cells) Sites   schema 
dense
 YU BAF170 K562  Yale ChIP-chip (BAF170 ab, K562 cells) Sites   schema 
dense
 YU BAF47 K562  Yale ChIP-chip (BAF47 ab, K562 cells) Sites   schema 
    
Data version: ENCODE Oct 2005 Freeze
Data coordinates converted via liftOver from: May 2004 (NCBI35/hg17)

Description

This track shows the map of -log10(P-value) of binding sites (as determined in the Methods below) for ChIP-chip using DNA from immunoprecipitated chromatin from either human HelaS3 (cervix epithelial adenocarcinoma), GM06990 (lymphoblastoid) or K562 (myeloid leukemia-derived) cells hybridized to maskless photolithographic arrays. The arrays consist of 50-mer oligonucleotides tiled with 12-nt overlaps covering most of the non-repetitive DNA sequence of the ENCODE regions. Chromatin immunoprecipitation was carried out for each experiment using antibodies against the following targets: BAF155, BAF170, INI1/BAF47, c-Fos, c-Jun, TAF1/TAFII250, RNA polymerase II, histone H4 tetra-acetylated lysine (H4Kac4), histone H3 tri-methylated lysine (H3K27me3), STAT1, nuclear factor kappa B (NFKB) p65, SMARCA4/BRG1, SMARCA6 and NRSF. Additionally, HeLa S3 cells immunoprecipitated with STAT1 were pre-treated with interferon-alpha and HeLa S3 cells immunoprecipitated with NFKB antibody were pre-treated with tumor necrosis factor-alpha (TNF-alpha) (see table below).

This track shows the combined results of three or four multiple biological replicates. For all arrays, the ChIP DNA was labeled with Cy5 and the control DNA was labeled with Cy3. These data are available at NCBI GEO (see table below for links), which also provides additional information about the experimental protocols.

Target GEO Accession(s) Description
BAF155 (H-76) GSE3549 (HeLa S3 cells) and GSE6898 (K562 cells) BAF155 (Brg1-Associated Factor, 155 kD) is a human homolog of yeast SWI3. The Swi-Snf chromatin-remodeling complex was first described in yeast, and similar proteins have been found in mammalian cells. The human Swi-Snf complex is comprised of at least nine polypeptides, including two ATPase subunits, Brm and Brg-1. Other members of the human Swi-Snf complex are termed BAFs for Brg1-associated factors. BAF155 is a conserved (core) component that stimulates the chromatin remodeling activity of Brg1.
BAF170 (H-116) GSE3550 (HeLa S3 cells) and GSE6896 (K562 cells) BAF170 (Brg1-Associated Factor, 170 kD) is a human homolog of yeast SWI3, a protein important in chromatin remodeling. It is a conserved (core) component of the Swi-Snf complex that stimulates the chromatin remodeling activity of Brg1 (see the description for BAF155).
INI1/BAF47 (H-300) GSE6897 (K562 cells) INI1 (Integrase Interactor 1) or BAF47 is a human homolog of yeast SNF5, a protein important in chromatin remodeling.
c-Fos GSE3449 (HeLa S3 cells) c-Fos (transcription factor) is the cellular homolog of the v-fos viral oncogene. It is a member of the leucine zipper protein family and its transcriptional activity has been implicated in cell growth, differentiation, and development. Fos is induced by many stimuli, ranging from mitogens to pharmacological agents. c-Fos has been shown to be associated with another proto-oncogene, c-Jun, and together they bind to the AP-1 binding site to regulate gene transcription. Like CREB, c-Fos is regulated by p90Rsk.
c-Jun GSE3448 (HeLa S3 cells) c-Jun (transcription factor), also known as AP-1 (activator protein 1), is the cellular homolog of the avian sarcoma virus oncogene v-jun, and as such can be referred to as a proto-oncogene.
TAF1/TAFII250 GSE3450 (HeLa S3 cells) TAF1 (TATA box binding protein (TBP)-associated factor, with molecular weight 250 kD, also known as TAFII250) is involved in the initiation of transcription by RNA polymerase II. It has histone acetyltransferase activity, which can relieve the binding between DNA and histones in the nucleosome. It is the largest subunit of the basal transcription factor, TFIID.
RNA polymerase II (N-20), N-terminus GSE6390 (HeLa S3 cells) and GSE6392 (GM06990 cells) RNA polymerase II (pol II) catalyzes transcription of DNA for the production of mRNAs and most snoRNAs.
RNA polymerase II (8WG16), C-terminus GSE6391 (HeLa S3 cells) and GSE6394 (GM06990 cells) RNA polymerase II (pol II) catalyzes transcription of DNA for the production of mRNAs and most snoRNAs. This antibody targets the pre-initiation complex form recognizing the C-terminal hexapeptide repeat of the large subunit of pol II. The initiation-complex form of RNA polymerase II is associated with the transcription start site.
H4Kac4 GSE6389 (HeLa S3 cells) and GSE6393 (GM06990 cells) H4Kac4 (Histone H4 tetra-acetylated lysine) is a post-translational modification of the histone which affects chromatin remodeling. Histone H4 is found in transcriptionally active euchromatin.
H3K27me3 GSE8073 (HeLa S3 cells) H3K27me3 (Histone H3 tri-methylated lysine) is a post-translational modification of the histone which affects chromatin remodeling. It is known to be associated with heterochromatin.
STAT1 p91 (C-24) GSE6892 (HeLa S3 cells, interferon-alpha stimulated) STAT1 (Signal Transducer and Activator of Transcription 1) responds to many cytokines and growth factors and regulates genes important for apoptosis, inflammation, and the immune system.
NFKB p65, N-terminus GSE6900 (HeLa S3 cells, TNF-alpha stimulated) NFKB p65 (RelA) is the strongest transcriptional-activator among the five members of the mammalian NF-kB/Rel family and plays an essential role in regulating the induction of genes involved in several physiological processes, including immune and inflammatory responses.
NFKB p65 (C-20), C-terminus GSE6899 (HeLa S3 cells, TNF-alpha stimulated) NFKB p65 (RelA) is the strongest transcriptional-activator among the five members of the mammalian NF-kB/Rel family and plays an essential role in regulating the induction of genes involved in several physiological processes, including immune and inflammatory responses.
SMARCA4/BRG1 GSE7370 (HeLa S3 cells) SMARCA4 (BRG1) is a catalytic subunit of the SWI/SNF chromatin remodeling complex. It is a member of the SNF2 family of chromatin remodeling ATPases.
SMARCA6 GSE7371 (HeLa S3 cells) SMARCA6 is a SNF2-like helicase linked to cell proliferation and DNA methylation. It is a member of the SNF2 family of chromatin remodeling ATPases.
NRSF GSE7372 (HeLa S3 cells) NRSF (neuron-restrictive silencer factor) represses neuron-specific genes in non-neuronal cells.

Display Conventions and Configuration

The subtracks within this annotation may be configured in a variety of ways to highlight different aspects of the displayed data. Data may be thresholded by score and/or the user can specify the display of only the top N scoring items (default is 200) for all the subtracks. The score for each item is indicated in grayscale, with darker shades corresponding to higher scores. The details page for an item (displayed after clicking on an item in the track) shows the top 20 highest scoring items displayed in the current window.

Methods

The data from replicates were quantile-normalized and median-scaled to each other (both Cy3 and Cy5 channels). Using a 1000 bp sliding window centered on each oligonucleotide probe, a signal map (estimating the fold enrichment [log2 scale] of ChIP DNA) was generated by computing the pseudomedian signal of all log2(Cy5/Cy3) ratios (median of pairwise averages) within the window, including replicates. Using the same procedure, a -log10(P-value) map (measuring significance of enrichment of oligonucleotide probes in the window) for all sliding windows was made by computing P-values using the Wilcoxon paired signed rank test comparing fluorensent intensity between Cy5 and Cy3 for each oligonucleotide probe (Cy5 and Cy3 signals from the same array). A binding site was determined by thresholding oligonucleotide positions with -log10(P-value) (>= 4), extending qualified positions upstream and downstream 250 bp, and requiring 1000 bp space between two sites. Top 400 sites are retained for experiments (ENCODE Oct 2005 Freeze) and for the other datasets, sites found using 1, 5 and 10% false discovery rates (FDR) are displayed.

Verification

ChIP-chip binding sites were verified by comparing "hit lists" generated from combinations of different biological replicates. Only experiments that yielded a significant overlap (greater than 50 percent) were accepted. As an independent check (for maskless arrays), data on the microarray were randomized with respect to position and re-scored; significantly fewer hits (consistent with random noise) were generated this way. Sites for data from Nov. 2006, Jan. 2007, Apr. 2007 and Jun. 2007 were determined with false discovery rates (FDR) of 1%, 5% and 10%. The lowest FDR which includes each "Site" is displayed on that site's details page. For the ENCODE Oct 2005 Freeze data (BAF155, BAF170, Fos, Jun and TAF1 in HeLa S3 cells), the top 400 sites are shown.

Credits

These data were generated and analyzed by the labs of Michael Snyder, Mark Gerstein and Sherman Weissman at Yale University.

References

Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 2004 Feb 20;116(4):499-509.

Euskirchen G, Royce TE, Bertone P, Martone R, Rinn JL, Nelson FK, Sayward F, Luscombe NM, Miller P, Gerstein M et al. CREB binds to multiple loci on human chromosome 22. Mol Cell Biol. 2004 May;24(9):3804-14.

Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, Luscombe NM, Rinn JL, Nelson FK, Miller P, Gerstein M et al. Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12247-52.

Quackenbush J. Microarray data normalization and transformation Nat Genet. 2002 Dec;32(Suppl):496-501.